MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - THEPARADISE.NG - A La Une - 29/Jul 21:55
FDA Approves Blood Test for Colorectal Cancer Screening in Adults
The U.S. Food and Drug Administration has approved the company Guardant Health’s Shield blood test for colorectal cancer screening in adults, 45 and older, who are at average risk for the disease. Photo Courtesy/guardanthealth via CNN Newsource By Jacqueline Howard, CNN (CNN) — The US Food and Drug Administration has approved a blood test to be [...] Read Full Article At: FDA Approves Blood Test for Colorectal Cancer Screening in Adults
Articles similaires
FDA Approves Tremfya for Ulcerative Colitis
drugs.com - 22:24
MONDAY, Sept. 16, 2024 -- The U.S. Food and Drug Administration has approved Tremfya (guselkumab) for the treatment of adults with moderately to...
FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
drugs.com - 12/Sep 08:09
South San Francisco, CA -- September 12, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S....
FDA Approves Tecentriq Hybreza (atezolizumab and hyaluronidase-tqjs) Subcutaneous Anti-PD-(L)1 Cancer Immunotherapy
drugs.com - 12/Sep 08:09
South San Francisco, CA -- September 12, 2024 -- Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S....
Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis
drugs.com - 13/Sep 07:09
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Tremfya (guselkumab) Receives U.S. FDA Approval for Adults with Moderately to Severely Active Ulcerative Colitis
drugs.com - 13/Sep 07:09
HORSHAM, Pa. (September 11, 2024) – Johnson & Johnson (NYSE: JNJ) today announced that the U.S. Food and Drug Administration (FDA) has approved...
Over 5 Million Americans Could Benefit If Psilocybin Approved for Depression: Study
drugs.com - 13/Sep 11:00
FRIDAY, Sept. 13, 2024 -- Over 5 million Americans could benefit if the U.S. Food and Drug Administration approves the "magic mushroom" psychedelic...
Over 5 Million Americans Could Benefit If Psilocybin Approved for Depression: Study
drugs.com - 13/Sep 11:00
FRIDAY, Sept. 13, 2024 -- Over 5 million Americans could benefit if the U.S. Food and Drug Administration approves the "magic mushroom" psychedelic...
U.S. lawmakers call out FDA for slow ‘smoke-free’ product review amid growing illegal market
westernstandardonline.com - 13/Sep 17:50
U.S. lawmakers and health groups are upset about how the Food and Drug Administration (FDA) is handling e-cigarettes and other smoke-free products.
U.S. lawmakers call out FDA for slow ‘smoke-free’ product review amid growing illegal market
westernstandardonline.com - 13/Sep 17:50
U.S. lawmakers and health groups are upset about how the Food and Drug Administration (FDA) is handling e-cigarettes and other smoke-free products.
Les derniers communiqués
-
Aucun élément